Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer. (Q39369722)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Maen Abdelrahim

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Sarah F Connelly

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Chris M Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Rafael Madero-Visbal

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Jimmie Colon

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Joshua Smith

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Pius Maliakal

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Riyaz Basha

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

2 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

72

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1648-1658

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Protective effects of green tea against prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The influence of finasteride on the development of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001-2002 National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Aspirin, salicylates, and cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Characterization of two polymorphic forms of tolfenamic acid, N-(2-methyl-3-chlorophenyl)anthranilic acid: their crystal structures and relative stabilities

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Therapeutic applications of NSAIDS in cancer special emphasis on tolfenamic acid

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Gastrointestinal tolerance studies on tolfenamic acid in humans and animals

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Regulation of the activity of Sp1-related transcription factors.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Nuclear receptor-mediated transactivation through interaction with Sp proteins

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Sp1 and Sp3 transcription factors upregulate the proximal promoter of the human prostate-specific antigen gene in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

An in vitro FluoroBlok tumor invasion assay.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Targeting Sp1 transcription factors in prostate cancer therapy.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Cell cycle checkpoints and their inactivation in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Androgen receptor signaling in androgen-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Prostate cancer and the met hepatocyte growth factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The two faces of transforming growth factor beta in carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Met, metastasis, motility and more

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Survivin, versatile modulation of cell division and apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The molecular basis and potential role of survivin in cancer diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Sp1 and Sp3 regulate basal transcription of the survivin gene

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

PI3K/Akt signalling pathway and cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Metastasis: a therapeutic target for cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Matrix metalloproteinases and tumor metastasis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Membrane type-matrix metalloproteinases and tumor progression.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Sp1 is upregulated in human glioma, promotes MMP‐2‐mediated cell invasion and predicts poor clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Indole-3-carbinol inhibits Sp1-induced matrix metalloproteinase-2 expression to attenuate migration and invasion of breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22518

21 January 2018

Identifiers

10.1002/PROS.22518

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22473873%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39369722&oldid=2278560223"